Category: Stock Market

The Regis Resources Ltd (ASX: RRL) share price is in focus today after the company reported strong growth in underground Ore Reserves at the Tropicana Gold Mine, with underground reserves growing over 500,000 ounces since 2021 and a material increase in confidence in long-term mine life.

What did Regis Resources report?

• Regis 30% share of Tropicana JV Mineral Resources is 26Mt at 1.9 g/t Au for 1.6Moz as at 31 December 2025.
• Regis 30% share of Tropicana JV Ore Reserves is 12Mt at 1.5 g/t Au for 0.6Moz as at 31 December 2025.
• Underground Ore Reserves within the Tropicana joint venture (100%) have grown by 0.2Moz net of depletion in CY25, now totalling 0.9Moz.
• Total Tropicana JV Ore Reserves (100%) stand at 1.9Moz, including 0.8Moz open pit, 0.9Moz underground, and 0.3Moz stockpiles.
• Since the initial underground Ore Reserve was declared in 2018, total underground reserve growth of 1.3Moz has exceeded depletion by around 500koz (100%).

What else do investors need to know?

Exploration at Tropicana in 2025 focused on both expanding known mineralisation and identifying new underground targets. Drilling increased confidence in down-plunge extensions and uncovered new areas to support upcoming resource definition.

Underground resource classifications improved, with Measured and Indicated Mineral Resources increasing to 2.5Moz from 2.2Moz, demonstrating ongoing replacement of mined ounces and supporting future project life.

The Tropicana JV’s work through the year has established a strong pipeline of underground growth projects, with further drilling planned to test high-priority zones like Boston Shaker, Havana, and the Cobbler conceptual target.

What did Regis Resources management say?

Chief Executive Officer and Managing Director Jim Beyer said:

It is very pleasing to see the Ore Reserves and Mineral Resources at Tropicana continue to grow and extend the mine life in line with our expectations. The ongoing, year on year growth delivered by the team is an excellent result for our shareholders and clearly continues the trend of underground Ore Reserves growth exceeding depletion. Impressively, before depletion, Ore Reserves within the undergrounds at Tropicana have grown by over 500k ounces of gold since 2021.

What’s next for Regis Resources?

Ongoing drilling at Tropicana is expected to further define and extend underground reserves, with several high-priority areas identified for exploration. Management remains confident that these initiatives will underpin the mine’s ability to generate strong cash flows well into the next decade.

The company continues to focus on replacing mined ounces each year, aiming to maintain a long mine life and robust resource base. Developments at Tropicana should support Regis Resources’ long-term growth strategy and deliver ongoing value for shareholders.

Regis Resources share price snapshot

Over the past 12 months, Regis Resources shares have risen 181%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 9% over the same period.

View Original Announcement

The post Regis Resources lifts underground reserves at Tropicana Gold Mine appeared first on The Motley Fool Australia.

More reading

• Stanmore Resources FY25 earnings: Record output
• West African Resources provides Burkina Faso government stake update
• Ampol FY25 earnings: profit jumps and dividend up
• Greatland Resources earnings: Bumper profit and revenue after first full Telfer half
• Regis Healthcare grows revenue and cash flow in H1 FY26 earnings

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Electro Optic Systems Holdings Ltd (ASX: EOS) shares are racing higher on Monday.

At the time of writing, the ASX defence stock is up 17% to $8.61.

This follows the release of its FY 2025 results before the market open.

EOS shares rise on results day

Investors have been buying EOS shares today despite it recording a drop in revenue for FY 2025.

It seems investors are instead focusing on a sharply strengthened order book, improved balance sheet, and signs that the company’s three-year turnaround has positioned it for growth.

According to the release, for FY 2025, EOS reported revenue from continuing operations of $128.5 million. This is down 27% year on year.

And while its gross margin improved significantly to 63%, up from 48% in FY 2024, underlying EBITDA came in at a loss of $24.4 million. This is wider than the prior year’s $11.6 million loss.

However, statutory net profit after tax was $17.5 million, boosted by a $91 million gain on the sale of EM Solutions.

While its earnings numbers were mixed, the market appears to be looking ahead.

Order book surges

A major highlight was EOS’ unconditional order book, which increased to $459 million at 31 December 2025. This is up 238% from $136 million a year earlier.

The ASX defence stock signed $424 million worth of contracts during the year, compared to just $70 million in FY 2024.

Key wins included a $125 million high energy laser weapon (HELW) export contract, a $108 million LAND 400-3 remote weapon systems contract, and multiple Slinger counter-drone system orders.

Management stated it aims to realise 40% to 50% of the current order book during 2026.

Importantly, the order book does not include the conditional US$80 million Korean laser weapon contract or any future contribution from the planned MARSS acquisition.

Balance sheet reset

EOS also materially strengthened its balance sheet during the year. All borrowings were repaid, and the company ended FY 2025 with $106.9 million in cash.

It has also secured a new $100 million term loan facility, which remains undrawn and available to support growth.

Positioned for a defence super-cycle

Management described 2025 as the final year of its three-year turnaround program and pointed to supportive global defence spending conditions.

The company has commercialised its high energy laser weapon system, expanded geographically into Europe and the Middle East, and announced the acquisition of MARSS to add AI-enabled command-and-control capabilities.

With a significantly larger order book, a clean balance sheet, and exposure to fast-growing counter-drone and space control markets, investors appear to be bidding EOS shares higher on the belief that FY 2026 could mark a return to earnings growth.

The post Why are EOS shares rocketing 17% today? appeared first on The Motley Fool Australia.

More reading

• ASX recap: 5 most traded shares last week
• Are Austal shares a buy, hold or sell after soaring 20% on Monday?
• Top brokers name 3 ASX shares to buy next week
• EOS shares crashed 44% from their all-time high last month. Is it time to sell?
• Top brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

There are a few ASX shares that numerous analysts like at the moment. When one expert rates a business as a buy, it’s interesting. When multiple brokers think a business is a buy, it could be an especially exciting opportunity to consider.

We are still in the middle of reporting season and some updates have been pleasing to analysts. When a business reports strong growth and still looks undervalued, then it could be a great buy today.

We’re going to look at two of the most appealing ASX shares available to Australians to buy today, based on the number of buy ratings.

Judo Capital Holdings Ltd (ASX: JDO)

Judo is a bank that is best known for providing loans to small and medium enterprises (SME), and unlocking a lot of funding for those loans via term deposits.

According to the Commsec collation of analyst opinions, there are currently 12 buy ratings on the ASX share.

In the half-year result, Judo reported that its gross loans and advances (GLA) increased 15% year-over-year and the net interest margin (NIM) improved 22 basis points (0.22%) to 3.03%, enabling a 46% rise in statutory net profit after tax (NPAT).

UBS is one of the brokers that rates Judo as a buy, with the numbers indicating “improving management confidence in lending book growth and NIM delivery”. The NIM was 1 basis point (0.01%) better than what market analysts were expecting.

Management has provided guidance that the NIM could expand to around 3.15% in the second half.

UBS believes Judo looks “well placed to benefit from structural tailwinds to business banking credit growth”. The broker is expecting the business to grow its earnings per share (EPS) at a compound annual growth rate (CAGR) of around 14.1% over the next three years.

The broker has a price target of $2.25 on the business and the $133 million net profit projection for FY26 implies the business is trading at 16x FY26’s estimated earnings.

TechnologyOne Ltd (ASX: TNE)

TechnologyOne is one of the largest software businesses on the ASX. It provides enterprise solutions for clients like local, state and federal governments, financial services, education, utilities, health and community services.

The Commsec collation of analyst opinions on the ASX share shows there are currently 13 buy ratings on the business.

TechnologyOne recently held its annual general meeting (AGM) which included some good news, helping offset some of the negativity surrounding potential AI threats to its future profitability.

UBS is one of the brokers that rates TechnologyOne as a buy.

The broker noted that at the AGM, it upgraded its expectations for profit before tax (PBT) to between 18% to 20%, up from the previous guidance of 13% to 17%. UBS is projecting 18.4% profit growth for TechnologyOne.

Additionally, the ASX share also gave new FY26 annual recurring revenue (ARR) growth guidance of between 16% to 18%. UBS thinks the ARR growth will be 18%.

UBS noted that TechnologyOne continues to target at least $1 billion of ARR by FY30. UBS thinks the ASX share will reach $1 billion of ARR by FY29.

On AI worries, the broker wrote:

i) TNE has sold 22 subscriptions for their new agentic AI-platform, Plus. At $75k/pa, early AI revenues are run-rating at $1.7m, since commercialisation just early Feb. Plus has seen the fastest takeup from customers versus other modules released by TNE, which gives us comfort on AI presenting as a direct monetisation avenue for TNE; ii) AI investment is all factored into PBT guidance and will see immediate PBT benefits, both on topline and on productivity.

TNE’s upgraded guidance today was expected but even then, still came in slightly above UBSe and cons numbers, which we view positively in light of recent concerns on AI disruption.

AI platform Plus’ early monetisation gives us comfort that AI could have potential to be a growth inflector over time.

UBS has a price target of $38.70 on the ASX share, implying significant potential for a share price recovery over the next year.

The post 2 ASX shares highly recommended to buy: Experts appeared first on The Motley Fool Australia.

More reading

• ASX 200 tech shares lead market sectors with a 7% bounce back
• These ASX 200 shares look stronger than their share prices suggest
• Buy, hold, sell: A2 Milk, Capstone Copper, and Judo Capital shares
• Bell Potter just upgraded this ASX 200 tech stock and is tipping a 20%+ return
• 5 things to watch on the ASX 200 on Thursday

Motley Fool contributor Tristan Harrison has positions in Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Caravel Minerals Ltd (ASX: CVV) has had good news regarding funding for its Western Australian copper project in recent days, which has piqued the interest of the team Canaccord Genuity, which has boosted the price target for the company in a recent report.

Caravel claims that its Caravel Copper Project is the largest undeveloped copper project in Australia, with mine studies projecting a 25 year mine life processing 30million tonnes of ore per year for 65,000 tonnes per year of copper.

Funding progressing

The company is currently working on a definitive feasibility study for the project, and just last week announced that two European bodies had signed non-binding letters of interest to fund the project.

Finnvera plc, Finland’s official Export Credit Agency, supplied the company with a non-binding letter of interest as did KfW IPEX, “a specialist provider of international project and export finance within the KfW Group in Germany”.

Caravel explained further:

The KfW IPEX letter of interest confirms interest in providing up to US$220 million in tied Finnvera backed senior debt as Senior Lender for the Caravel Copper Project, subject to satisfactory due diligence (including environmental and social), all approvals, execution of finance documentation satisfactory to KfW IPEX, and fulfilment of applicable conditions precedent. Export Credit Agency funding is expected to form a key component of Caravel’s diversified funding stack, alongside project offtake partner equity, precious metal streaming, mining fleet finance, and traditional project debt. The company continues to advance discussions with multiple parties to secure a comprehensive financing package for Project development.

Caravel mananing director Don Hyma said the letters of interest marked significant progress for the company’s financing plans for the mine.

Mr Hyma added:

We are following a structured process to deliver a timely finance solution for the project and our shareholders. These letters of interest underscore strong international supply chain interest in our strategically significant copper and molybdenum product streams – recognised as critical minerals in multiple global jurisdictions – and strengthen our pathway to a multi-source funding package as we advance towards a final investment decision.

The funding announcement followed another significant milestone in November, when Caravel signed a non-binding memorandum of understanding with a subsidiary of Adani Enterprises, Kutch Copper, which could lead to either direct funding from Kutch, or potentially an offtake agreement covering all of the mine’s output.

Shares looking cheap

The analysts at Canaccord Genuity have assessed the most recent announcement and have upgraded their price target for Caravel shares from 60 cents to 80 cents.

They note that the process plant design for the mine is about 90% complete and progress had been made on several fronts to feed into the definitive feasibility study.

Caravel shares are currently changing hands for 40 cents. The company was valued at $223.5 million at the close of trade on Friday.

The post This copper project developer could double in value, analysts say appeared first on The Motley Fool Australia.

More reading

• Stanmore Resources FY25 earnings: Record output
• Why is this ASX 300 stock jumping 14% on Monday?
• Guess which ASX 300 healthcare share is storming higher on an 18% revenue boost
• West African Resources provides Burkina Faso government stake update
• 5 ASX ETFs to buy with $50,000 today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Stanmore Resources Ltd (ASX: SMR) share price is in focus today, after the company revealed record production of 20.5 million tonnes in FY25 and delivered underlying EBITDA of US$385 million despite coal market headwinds.

What did Stanmore Resources report?

• Total revenue fell to US$1.88 billion, down from US$2.40 billion last year, reflecting a 21% drop in average realised sale prices.
• Underlying EBITDA came in at US$385 million, supported by lower FOB cash costs of US$88 per tonne.
• Net loss after tax of US$47 million, down from a profit of US$192 million in FY24.
• Free cash flow of US$296 million, with closing cash of US$212 million.
• A fully franked final dividend of 8.9 US cents per share was declared.
• Net debt finished the year at just US$33 million, with total liquidity of US$482 million.

What else do investors need to know?

Stanmore Resources’ record output was achieved despite a challenging first half hampered by severe weather, with strong operational recovery in the second half. The company’s major projects, including the Isaac Downs Extension, made regulatory progress, while South Walker Creek and Poitrel mines continued to drive performance.

Management highlighted cost discipline as a key factor in offsetting falling coal prices, with FOB cash costs slightly below the prior year. Operational efficiencies and a return to lower, steady-state capital expenditure supported robust cash generation and ongoing shareholder returns.

What did Stanmore Resources management say?

Chief Executive Officer & Executive Director Marcelo Matos said:

The 2025 full year was another expansionary year for Stanmore, with production increasing following the completion of our recent capital investment program… Stanmore remains uniquely positioned to benefit as an Australian-based pure-play producer.

What’s next for Stanmore Resources?

Looking ahead, Stanmore is forecasting a modest step down in consolidated production to 12.8–13.4 million tonnes in FY26, mainly due to changes at the Isaac Plains Complex. The company expects slightly higher FOB cash costs in 2026, reflecting industry-wide pressure from inflation and FX movements, though ongoing operational improvements are expected to mitigate these impacts.

Stanmore intends to maintain its focus on operational efficiency, cost management, and advancing development projects such as the Isaac Downs Extension. It also remains committed to returning capital to shareholders, supported by its strong balance sheet and liquidity.

Stanmore Resources share price snapshot

Over the past 12 months, Stanmore Resources shares have risen 6%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 9% over the same period.

View Original Announcement

The post Stanmore Resources FY25 earnings: Record output appeared first on The Motley Fool Australia.

More reading

• West African Resources provides Burkina Faso government stake update
• Ampol FY25 earnings: profit jumps and dividend up
• Greatland Resources earnings: Bumper profit and revenue after first full Telfer half
• Regis Healthcare grows revenue and cash flow in H1 FY26 earnings
• Lendlease half-year results: $318m loss, construction steady, capital recycling on track

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Clarity Pharmaceuticals Ltd (ASX: CU6) shares are having a strong start to the week.

At the time of writing on Monday, the ASX 300 stock is up 14% to $4.00.

Why is this ASX 300 stock jumping?

Investors have been buying Clarity Pharmaceuticals shares after it announced another patient in its SECuRE Phase II trial achieved undetectable disease following treatment with its 67Cu-SAR-bisPSMA therapy.

According to the release, a 76-year-old participant with metastatic castration-resistant prostate cancer (mCRPC) achieved undetectable prostate-specific antigen (PSA) levels just seven weeks after the first treatment cycle. After the second cycle, a PSMA PET scan showed no detectable disease.

Importantly, the company noted that all related adverse events were mild (Grade 1), with no haematological or renal side effects observed to date.

This marks the fifth patient in Clarity’s SAR-bisPSMA theranostic program to achieve undetectable disease by radiographic assessment.

Building momentum in SECuRE trial

Clarity also provided an update on a previously reported patient in the same Cohort Expansion Phase. That participant continues to show undetectable disease after four treatment cycles, with no new safety signals observed.

The SECuRE trial is a Phase I/IIa theranostic study evaluating 64Cu-SAR-bisPSMA for imaging and 67Cu-SAR-bisPSMA for therapy in patients with advanced prostate cancer. Recruitment into the Cohort Expansion Phase is ongoing, with completion expected in 2026.

Planning for a registrational Phase III trial is also underway based on data generated so far.

Management commentary

Commenting on the news, the ASX 300 stock’s executive chair, Dr Alan Taylor, said:

The momentum of data we are generating with our lead SAR-bisPSMA product in both theranostic and diagnostic trials is strong, with excellent results to date on all fronts. We are beyond excited to see yet another patient achieve undetectable disease following their 67Cu-SARbisPSMA treatments.

What is particularly outstanding is that this new patient presented with undetectable PSA just 7 weeks after his first 8 GBq cycle, with a negative PSMA PET being reported after the second cycle. This result is particularly impressive given this participant has been battling prostate cancer for 15 years and is now free of any detectable disease based on PSA and PET assessments with only mild (Grade 1) AEs.

Speaking about the “extraordinary” outcome, Taylor then adds:

While this outcome is extraordinary, we now know this is not just luck or coincidence. Despite the number of participants in the SECuRE trial being relatively small, this is now the fifth time we have seen a patient present with undetectable disease following their 67Cu-SAR-bisPSMA treatments, and study recruitment is still ongoing.

We are also excited to see that the previous participant in the Cohort Expansion Phase of the SECuRE trial to achieve undetectable disease observed by anatomical and molecular imaging2 continues to show undetectable disease during his last follow up in February 2026, following the fourth 67Cu-SAR-bisPSMA cycle. This is especially encouraging as this participant had bone metastasis at study entry and now continues to report excellent quality of life after his treatment with 67Cu-SAR-bisPSMA.

The post Why is this ASX 300 stock jumping 14% on Monday? appeared first on The Motley Fool Australia.

More reading

• Why this ASX 300 stock could be a buy after ‘a breakthrough moment’
• Guess which ASX 300 stock is jumping 18% on big news
• Argo Investments reports record profit and dividend
• Are these 2 ASX healthcare shares a buying opportunity after yesterday’s crash?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 300 Index (ASX: XKO) healthcare share Regis Healthcare Ltd (ASX: REG) is charging higher today.

Shares in the residential aged care provider closed on Friday trading for $6.44. In early morning trade on Monday, shares are changing hands for $6.86 apiece, up 6.5%.

For some context, the ASX 300 is up 0.2% at this same time.

Here’s why Regis Healthcare shares are outperforming today.

ASX 300 healthcare share jumps on revenue surge

Regis Healthcare shares are lifting off today following the release of the company’s half-year earnings results (H1 FY 2026).

Notably, the ASX 300 healthcare share achieved an 18% year-on-year increase in its revenue from services to $667.7 million.

Management credited the revenue growth to higher AN-ACC (Australian National Aged Care Classification) pricing, improved occupancy, and the company’s recent acquisitions of Ti Tree Operations, Rockpool, and OC Health. Those acquisitions added a combined eight homes and more than 1,000 beds to Regis Healthcare’s national portfolio.

Earnings also lifted, with H1 FY 2026 underlying earnings before interest, taxes, depreciation and amortisation (EBITDA) up 4% to $70.6 million.

And net operating cash flow surged 40% from H1 FY 2025 to $291.7 million. That big boost was driven by net refundable accommodation deposits (RADs) cash inflow of $178.5 million.

On the bottom line, the ASX 300 healthcare share reported underlying net profit after tax (NPAT) of $29.7 million, broadly in line with H1 FY 2025.

Statutory NPAT of $13.4 million was down 45% year on year, impacted by one-off costs that were mostly related to Regis’ acquisitions over the six months.

As for passive income, the board declared a fully-franked interim dividend of 9 cents per share, up 11.1% from last year’s interim payout (which was only 60% franked).

Regis Resources had net cash of $198 million as at 31 December, up 10% year on year.

What did management say?

Commenting on the results boosting the ASX 300 healthcare share today, Regis managing director and CEO Linda Mellors said:

Our half-year results demonstrate the resilience and momentum of the business as we continue to operate in a rapidly evolving operating environment. We remain focused on delivering high-quality care while advancing our growth strategy, supported by high occupancy and continued investment in our people and service offering…

Looking to what’s ahead for Regis Healthcare shares, Mellors added:

We have successfully ramped up our Camberwell home in its first year, and we are progressing the greenfield pipeline with Toowong and Carlingford under construction.

At the same time, we continue to invest in strategic initiatives that support the long-term success of the business. With an active pipeline of M&A opportunities and nine greenfield development opportunities, Regis is well-positioned for continued growth.

The post Guess which ASX 300 healthcare share is storming higher on an 18% revenue boost appeared first on The Motley Fool Australia.

More reading

• Regis Healthcare grows revenue and cash flow in H1 FY26 earnings

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The West African Resources Ltd (ASX: WAF) share price is in focus today as the company clarified recent government moves regarding its Kiaka gold project in Burkina Faso. WAF reported that Burkina Faso’s government is considering acquiring an additional 25% stake in Kiaka SA, but stressed that current operations remain unaffected and engagement with the government is ongoing.

What did West African Resources report?

• The Burkina Faso government is considering a draft decree to authorise acquisition of a further 25% equity in Kiaka SA.
• Talks are underway to ensure any changes respect WAF shareholders’ and lenders’ financial interests.
• Cooperation discussions continue between WAF and government-owned SOPAMIB for new mining projects.
• Operations at Sanbrado and Kiaka mines have continued as normal throughout these engagements.

What else do investors need to know?

WAF confirmed that while the government’s interest in Kiaka SA has attracted media attention, there has been no final decision and talks are continuing in a constructive manner. Importantly, the ongoing discussions are focused only on Kiaka SA and do not affect WAF’s other projects, like Sanbrado and Toega.

The company highlighted that, through SOPAMIB, the Burkina Faso government is interested in expanding national involvement in mining projects that can create jobs, spur economic benefits, and unlock greater value from the country’s resources.

What did West African Resources management say?

Executive Chairman and CEO Richard Hyde said:

We appreciate the constructive engagement and continued support of the Government of Burkina Faso. Our discussions with the Government regarding the ownership structure of Kiaka and the potential for cooperation on new projects have reflected a shared vision to develop a strong and sustainable mining industry that benefits the Burkinabé people and delivers long-term value for all stakeholders. Operations at Sanbrado and Kiaka have continued unaffected throughout this engagement with the Government.

What’s next for West African Resources?

West African Resources intends to maintain its collaborative approach in dealings with the Burkina Faso government and SOPAMIB. The main objective is to reach an agreement that balances government interests and provides value for WAF’s shareholders and lenders.

Looking ahead, WAF remains committed to growing its mining operations in Burkina Faso. The company also sees opportunities for new joint mining projects with the government, focusing on sustainable industry development and local community benefits.

West African Resources share price snapshot

Over the past 12 months, the West African Resources shares have risen 109%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 9% over the same period.

View Original Announcement

The post West African Resources provides Burkina Faso government stake update appeared first on The Motley Fool Australia.

More reading

• Stanmore Resources FY25 earnings: Record output
• Ampol FY25 earnings: profit jumps and dividend up
• Greatland Resources earnings: Bumper profit and revenue after first full Telfer half
• Regis Healthcare grows revenue and cash flow in H1 FY26 earnings
• Lendlease half-year results: $318m loss, construction steady, capital recycling on track

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

If you have $50,000 ready to invest, exchange traded funds (ETFs) can offer instant diversification without the need to pick individual winners.

Instead of relying on the usual suspects, here are five less followed ASX ETFs that provide exposure to quality, global growth, and structural trends. Combined, they could form the backbone of a well-rounded portfolio.

Here’s what they offer investors:

VanEck Morningstar Wide Moat AUD ETF (ASX: MOAT)

The VanEck Morningstar Wide Moat ETF focuses on US stocks that are judged to have sustainable competitive advantages and are trading at attractive valuations.

Current holdings include Huntington Ingalls Industries (NYSE: HII), Constellation Brands (NYSE: STZ), and Bristol-Myers Squibb (NYSE: BMY). These are established businesses with strong earnings power.

Rather than chasing hype, this fund leans into quality at reasonable prices. That approach has historically delivered strong long-term results and may appeal to investors who prefer discipline over speculation.

Betashares India Quality ETF (ASX: IIND)

India is one of the fastest-growing major economies in the world. The Betashares India Quality ETF provides exposure to high-quality Indian stocks that are screened for profitability and financial strength.

This is not a blanket bet on emerging markets. Instead, it targets companies that are positioned to benefit from India’s expanding middle class, urbanisation, and digital transformation.

For investors seeking long-term growth outside traditional Western markets, the Betashares India Quality ETF adds geographic diversification with a quality tilt.

The team at Betashares recently recommended the fund.

Betashares Global Cybersecurity ETF (ASX: HACK)

Cybersecurity spending is increasingly non-discretionary.

The Betashares Global Cybersecurity ETF holds stocks such as Palo Alto Networks (NASDAQ: PANW), CrowdStrike (NASDAQ: CRWD), and Fortinet (NASDAQ: FTNT). These firms provide essential infrastructure to protect businesses and governments from cyber threats.

As digital activity expands, so does the attack surface. That makes cybersecurity a structural growth theme that could persist for decades.

Betashares Global Cash Flow Kings ETF (ASX: CFLO)

The Betashares Global Cash Flow Kings ETF focuses on global stocks generating strong free cash flow.

Holdings include Alphabet (NASDAQ: GOOGL), Visa (NYSE: V), and ASML Holding (NASDAQ: ASML). These businesses convert a large share of revenue into cash, giving them flexibility to reinvest, pay dividends, or buy back shares. It was recently recommended as a buy by Betashares.

Betashares Global Robotics and Artificial Intelligence ETF (ASX: RBTZ)

A final ASX ETF to look at for the $50,000 is the Betashares Global Robotics and Artificial Intelligence ETF. It targets stocks involved in robotics, automation, and artificial intelligence.

Its portfolio includes Intuitive Surgical (NASDAQ: ISRG), Nvidia (NASDAQ: NVDA), and ABB Ltd (SWX: ABBN). These firms operate at the heart of hardware, software, and industrial automation.

AI and robotics are reshaping industries from healthcare to manufacturing. As a result, this could be a theme with decades of runway. It was also recommended by analysts at Betashares.

The post 5 ASX ETFs to buy with $50,000 today appeared first on The Motley Fool Australia.

More reading

• 3 top ASX ETFs to buy and hold in an SMSF
• The best ASX ETFs to buy and hold for 10 years or more
• 3 ASX ETFs to buy with $30,000 in February
• 5 ASX ETFs for new investors to buy and hold
• I think these 2 exotic ASX ETFs are a buy in 2026

Motley Fool contributor James Mickleboro has positions in VanEck Morningstar Wide Moat ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ASML, Abb, Alphabet, BetaShares Global Cybersecurity ETF, Bristol Myers Squibb, CrowdStrike, Fortinet, Intuitive Surgical, Nvidia, and Visa. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Constellation Brands and Palo Alto Networks and has recommended the following options: long January 2028 $520 calls on Intuitive Surgical and short January 2028 $530 calls on Intuitive Surgical. The Motley Fool Australia has recommended ASML, Alphabet, CrowdStrike, Nvidia, VanEck Morningstar Wide Moat ETF, and Visa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Ampol Ltd (ASX: ALD) share price is in focus after the company posted an 83% jump in RCOP NPAT to $429 million for FY 2025, alongside a fully franked final dividend of 60 cents per share.

What did Ampol report?

• Group RCOP EBITDA up 20% to $1.44 billion
• RCOP Net Profit After Tax (NPAT) rose 83% to $429 million
• Statutory NPAT of $82.4 million, down 33% year on year
• Full year fully franked dividends totalled 100 cents per share
• Leverage ratio at 2.3x Adjusted Net Debt/RCOP EBITDA
• Convenience Retail, Fuels and Infrastructure, and New Zealand all delivered earnings growth

What else do investors need to know?

Ampol made progress on several strategic priorities, including continuing to work towards its proposed acquisition of EG Australia, with completion expected mid-year subject to regulatory approval. The sale of interests in Channel Infrastructure and a divestment from electricity retailing have bolstered the company’s balance sheet.

In Convenience Retail, network shop sales (excluding tobacco and U-GO conversions) grew 2.8%, supported by higher margins from the QSR, beverages, and bakery categories. Ampol continued to shift away from tobacco, which now represents a smaller share of overall sales and margins.

The Fuels and Infrastructure segment benefited from a strong rebound in Lytton refinery performance, with production up to 5.5 billion litres for the year and significantly improved refining margins compared to FY 2024.

What did Ampol management say?

Managing Director and CEO Matt Halliday said:

The financial performance in 2025 is a high quality and broad-based result that reflects the steps taken in recent years to strengthen our delivery and increase our exposure to the more stable and growing business segments. The 5-year compound annual growth rate of the combined EBIT from these businesses is about 11 per cent including the contribution through the acquisition of Z Energy.

What’s next for Ampol?

Ampol enters 2026 with positive momentum, especially in Convenience Retail and New Zealand, thanks to continued store execution and favourable retail margins. The company is engaging with government on the Fuel Security Services Payment review and advancing expansion projects such as the Ultra Low Sulfur Fuels project, which is targeted to commence commissioning in the second quarter.

The proposed EG Australia acquisition remains a strategic focus, with the competition regulator’s decision expected in June 2026. Ampol is confident in its ability to deliver on its investment and growth goals, leveraging its strong retail platforms and integrated supply chain.

Ampol share price snapshot

Over the past 12 months, Ampol shares have risen 6% trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 9% over the same period.

View Original Announcement

The post Ampol FY25 earnings: profit jumps and dividend up appeared first on The Motley Fool Australia.

More reading

• Stanmore Resources FY25 earnings: Record output
• West African Resources provides Burkina Faso government stake update
• Greatland Resources earnings: Bumper profit and revenue after first full Telfer half
• Regis Healthcare grows revenue and cash flow in H1 FY26 earnings
• Lendlease half-year results: $318m loss, construction steady, capital recycling on track

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.